Related Experiment Video
Updated: May 25, 2025

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury
Luyao Wang1,2, Wenliya Dong1, Lei Fan1,2
1State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Background And Aims:
Alcohol-associated liver disease (ALD) represents a critical global health challenge characterized by liver damage resulting from excessive alcohol consumption. Early detection and timely intervention are essential for optimizing patient outcomes. However, the mechanisms underlying alcohol-induced liver injury have not been fully elucidated. Fibroblast growth factor 4 (FGF4) has been implicated in the progression of various liver diseases. This study aims to elucidate the role of FGF4 in the pathogenesis of ALD.
Approach And Results:
We analyzed human liver specimens and observed significant upregulation of FGF4 mRNA and protein levels in patients with ALD. Consistent findings were noted in mouse models subjected to a Lieber-DeCarli liquid diet. Importantly, hepatic FGF4 expression exhibited a positive correlation with ALD severity in both human subjects and murine models. Hepatocyte-specific deletion of Fgf4 ( Fgf4 -LKO) exacerbated alcohol-induced liver injury through increased oxidative stress, inflammation, and apoptosis. Specifically, Fgf4 -LKO mice demonstrated heightened susceptibility to ethanol plus CCl 4 -induced fibrosis and liver injury. However, treatment with the ERRγ inverse agonist GSK5182 and CYP2E1 inhibitor chlormethiazole (CMZ) mitigated the exacerbated liver injury associated with Fgf4 deficiency. Mechanistic investigations revealed that FGFR4 phosphorylates ERRγ, promoting its ubiquitination and degradation in hepatocytes. Hepatic-specific knockout of Fgfr4 intensified alcohol-induced liver injury and nullified the protective conferred of recombinant FGF4 △NT .
Conclusions:
Our study identifies FGF4 as a stress-responsive regulator in liver pathophysiology, operating through an FGFR4-mediated ERRγ-CYP2E1 signaling pathway. These results underscore the potential of FGF4 and its downstream pathways as therapeutic targets for ALD treatment.
Insights
Fibroblast growth factor 4 (FGF4) is upregulated in alcohol-associated liver disease (ALD) and worsens liver injury by degrading ERRγ. Targeting FGF4 may offer new treatments for ALD.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Alcohol-associated liver disease (ALD) is a major health concern with unclear injury mechanisms.
- Fibroblast growth factor 4 (FGF4) is implicated in liver disease progression.
Purpose of the Study:
- To investigate the role of FGF4 in the pathogenesis of alcohol-associated liver disease (ALD).
Main Methods:
- Analysis of human liver specimens and mouse models of ALD.
- Investigated the effects of hepatocyte-specific Fgf4 deletion and Fgfr4 knockout.
- Utilized ERRγ inverse agonist GSK5182 and CYP2E1 inhibitor chlormethiazole (CMZ).
Main Results:
- FGF4 mRNA and protein levels are elevated in ALD patients and mouse models, correlating with disease severity.
- Hepatocyte-specific Fgf4 deletion exacerbated liver injury, increasing oxidative stress, inflammation, and apoptosis.
- FGFR4-mediated phosphorylation and degradation of ERRγ by FGF4 was identified as a key mechanism.
- Targeting FGFR4 or downstream pathways mitigated alcohol-induced liver injury.
Conclusions:
- FGF4 acts as a stress-responsive regulator in liver pathophysiology via an FGFR4-ERRγ-CYP2E1 pathway.
- FGF4 and its downstream signaling pathways represent potential therapeutic targets for ALD.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cell Specific Gene Expression
Enzyme Inhibition

